A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver
Grupo Espanol de Investigacion en Sarcomas
Memorial Sloan Kettering Cancer Center